Both healthy control- and MDS-MSCs showed positive expression for stroma cell markers such as CD146, CD271, CD105, CD73, and CD90 that were not significantly differentially expressed between these two groups (Supplemental Fig. 1a, b). Here, MCAM is linked to myelodysplastic syndrome.